ITW
62
-2
CTAS
56
-5
BF.B
57
7
MSFT
54
-3
EIX
69
-5
CA
36
-4
HRL
38
2
SIG
58
-2
IFF
60
-3
JBHT
49
3
FLS
46
-7
M
14
2
PLD
51
-5
SE
65
4
FAST
46
-2
VFC
57
4
CME
56
-3
HSIC
56
3
PNR
72
-2
STZ
54
-4
ITW
62
-2
CTAS
56
-5
BF.B
57
7
MSFT
54
-3
EIX
69
-5
CA
36
-4
HRL
38
2
SIG
58
-2
IFF
60
-3
JBHT
49
3
FLS
46
-7
M
14
2
PLD
51
-5
SE
65
4
FAST
46
-2
VFC
57
4
CME
56
-3
HSIC
56
3
PNR
72
-2
STZ
54
-4
Financhill
Back

Regeneron Pharmaceuticals Quote, Financials, Valuation and Earnings

Hedge fund manager warns about the market ahead

Free book prepares you for the coming uncertainty in the stock market
Buy
64

REGN
Regeneron Pharmaceuticals

Last Price:
1,150.22
Seasonality Move:
4.55%

7 Day Trial

ALL ACCESS PASS

$ 7

"The Next Apple?" - Mode's Growth Story is Turning Heads

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Regeneron Pharmaceuticals Price Quote

$1,150.22
+11.41 (+1%)
(Updated: September 19, 2024 at 6:50 PM ET)

Regeneron Pharmaceuticals Key Stats

Buy
64
Regeneron Pharmaceuticals (REGN) is a Buy
Day range:
$1,137.64 - $1,156.40
52-week range:
$769.19 - $1,211.20
Dividend yield:
0%
P/E ratio:
32.75
P/S ratio:
9.66
P/B ratio:
4.45%
Volume:
326.7K
Avg. volume:
439.1K
1-year change:
38.12%
Market cap:
$125.5B
Revenue:
$13.1B
EPS:
$37.76

How Much Does Regeneron Pharmaceuticals Make?

Is Regeneron Pharmaceuticals Growing As A Company?

Regeneron Pharmaceuticals Stock Price Performance

What Is Regeneron Pharmaceuticals 52-Week High & Low?

Regeneron Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy Regeneron Pharmaceuticals?

Is Regeneron Pharmaceuticals Cash Flow Positive?

  • What Is REGN Cash Flow From Operations?
    Cash flow from operations (TTM) is $4.1B
  • What Is Regeneron Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.3B
  • What Is Regeneron Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$2.8B

Regeneron Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    REGN return on invested capital is 15.43%
  • What Is Regeneron Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 12.99%
  • What Is REGN Return On Equity?
    ROE is a measure of profitability and is 16.61%

Regeneron Pharmaceuticals Earnings Date & Stock Price

Regeneron Pharmaceuticals Competitors

Regeneron Pharmaceuticals Dividend Yield

Regeneron Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 46% 8.83%
Revenue: 12.32% 4.51%

Analyst Recommendations

Buy Recommendations: 12
Hold Recommendations: 5
Sell Recommendations: 1
Price Target: 1,162.19
Upside from Last Price: 2.05%

Major Shareholders

  • How many REGN shares are owned by institutional investors?
    171.5M REGN shares are owned by institutional investors
  • How many REGN shares are owned by insiders?
    2.1M REGN shares are owned by insiders